Dezember 9, 2020

Grifols is included on Euronext Vigeo indices and recognized once again as one of the world's most sustainable companies

  • For the first time ever, Grifols has been included on the Euronext Vigeo Europe 120 and Euronext Vigeo Eurozone 120 indices based on the evaluation by Vigeo Eiris, the prestigious rating agency that assesses the performance of the 120 most sustainable listed companies in Europe
  • As of this year, Grifols also forms part of the Dow Jones Sustainability Index (DJSI) Europe and since 2018, the FTSE4Good Global, FTSE4Good Europe and FTSE4Good Ibex indices
  • In addition, Grifols improves its Carbon Disclosure Project (CDP) rating and is positioned as one of the leading companies against climate change

Barcelona, December 9, 2020.- Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare leader in the production of plasma-derived medicines with a proven track record of more than 100 years dedicated to enhancing the health and well-being of people worldwide, has been recognized once again as one of the world’s most sustainable companies. For the first time in its history, the company has been included on the Euronext Vigeo Europe 120 and Euronext Vigeo Eurozone 120 indices, ranking among the top three European companies in its sector.

The Euronext Vigeo index is a twice-yearly ranking of the 120 most sustainable listed companies based on the assessment by Vigeo Eiris, a rating agency that evaluates organizations’ performance according to environmental, social and governance (ESG) criteria.

Grifols also achieved a higher Carbon Disclosure Project (CDP) rating, the world's leading environmental information platform that annually assesses corporate strategies and performance in relation to climate change. The company has increased its qualification in recent years, reaching an “A-” management rating in 2020.

For Raimon Grifols and Víctor Grífols Deu, co-CEOs of Grifols, “After the company’s inclusion on the Dow Jones Sustainability Index, this new recognition by Vigeo Eiris and the improvement in the Carbon Disclosure Project rating are two milestones that reaffirm our solid commitment to sustainability, which has guided Grifols since its creation more than 100 years ago.
COVID-19 has generated numerous challenges. At Grifols, we believe that now more than ever, we need to provide transparency on social and environmental issues at all organizational levels, supported by a robust corporate governance structure. This objective is key as the company continues to build on its commitment to enhance the health and well-being of donors, patients and society.
The distinctions awarded underline our transparency and reporting efforts in recent years and encourages us to continue working in the same direction.


A broad range of financial market players consider ESG indices when making their investment decisions.

Grifols has been listed on the Dow Jones Sustainability Index (DJSI) Europe since November 2020 and on the sustainability indices FTSE4Good Global, FTSE4Good Europe and FTSE4Good Ibex since 2018.